# Neurogene Inc.: Form 8-K, filed Nov 21, 2024

- Company: [Neurogene Inc.](/companies/ngne.md) (CIK 1404644)
- Form: 8-K
- Filed: 2024-11-21
- Accepted by EDGAR: Nov 21, 2024, 21:01 ET
- Period: 2024-11-20
- Accession: 0001404644-24-000109
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1404644/000140464424000109/ngne-20241120.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1404644/000140464424000109/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1404644/000140464424000109/ngne-20241120.htm

Filed Nov 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001404644-24-000109. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.